官方服务：
资源简介：
Tamoxifen-resistant human breast cancer cell lines
应用场景：
创建时间：
2009-12-09
相关数据集
Novel long non‐coding RNA 005620 induces epirubicin resistance of triple-negative breast cancer via regulating ITGB1 expression. Novel long non‐coding RNA 005620 induces epirubicin resistance of triple-negative breast cancer via regulating ITGB1 expression
In this study, a total of 12 differentially expressed lncRNAs were established through lncRNA sequencing analysis. Lnc005620 is one of the novel intronic lncRNAs which is highly expressed in Epi-R MDA
NIAID Data Ecosystem80
HBCx_22_scChIPseq_mm10_50kb.tsv
The samples correspond to the mouse cells from patient-derived xenograft (PDX) originating from two different human donors. The HBCx-22 and HBCx-22-TamR datasets correspond to mouse cells from a pair
NIAID Data Ecosystem30
Promoter methylation data: OHT/ICI-sensitive vs. -resistant cell lines
MCF7 breast cancer cell lines: drug-resistant (OHT and ICI) cell lines vs. drug-sensitive (wild type) cell lines. Assessment of association between gene expression and methylation. Two comparisons: OH
NIAID Data Ecosystem20
RANK expression and Luminal BC response to CDK4/6 inhibitors
The combination of endocrine therapy (ET) with CDK4/6 inhibitors (CDK4/6i) was the most recent life-changing hallmark in metastatic Luminal breast cancer (BC). However, intrinsic and acquired resistan
NIAID Data Ecosystem40
Sequencing mutations in selected genes form circulating tumor cells (metastatic breast cancer)
The study goal is to evaluate genetic heterogeneity of circulating tumor cells (CTC) isolated from the blood of patients with metastatic breast cancer. Single CTCs were isolated using EpCAM-independen
NIAID Data Ecosystem20
